Alerts will be sent to your verified email
Verify Email
OXYGENTAPH
|
Oxygenta Pharma
|
Aarey Drugs & Pharma
|
Syschem (India)
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.02 % | 4.4 % | -15.43 % |
|
5yr average Equity Multiplier
|
-1.71 | 2.28 | 5.54 |
|
5yr Average Asset Turnover Ratio
|
1.26 | 1.58 | 1.2 |
|
5yr Avg Net Profit Margin
|
-10.07 % | 1.23 % | -1.1 % |
|
Price to Book
|
0.0 | 1.36 | 2.21 |
|
P/E
|
0.0 | 56.29 | 46.33 |
|
5yr Avg Cash Conversion Cycle
|
-21.7 Days | 60.21 Days | 2.82 Days |
|
Inventory Days
|
80.38 Days | 21.8 Days | 86.99 Days |
|
Days Receivable
|
20.8 Days | 122.43 Days | 74.65 Days |
|
Days Payable
|
154.17 Days | 103.05 Days | 168.44 Days |
|
5yr Average Interest Coverage Ratio
|
-3.16 | 3.59 | 8.6 |
|
5yr Avg ROCE
|
-3.19 % | 8.53 % | -1.51 % |
|
5yr Avg Operating Profit Margin
|
-9.3 % | 1.54 % | 1.15 % |
|
5 yr average Debt to Equity
|
-1.91 | 0.22 | 0.49 |
|
5yr CAGR Net Profit
|
n/a | -9.19 % | n/a |
|
5yr Average Return on Assets
|
-6.87 % | 1.94 % | -0.74 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.95 % | 44.8 % | 56.71 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
45.62 % | -5.23 % | 4.61 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.04 % | 0.0 | 0.0 |
|
Oxygenta Pharma
|
Aarey Drugs & Pharma
|
Syschem (India)
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|